Previous 10 | Next 10 |
Gainers: RTI Surgical RTIX +66% . More news on: IRIDEX Corporation, Inpixon, Gritstone Oncology, Inc., Stocks on the move, , Read more ...
On a preliminary basis , IRIDEX (NASDAQ: IRIX ) expects Q4 and full-year revenues of $11.6M - 11.8M and $43.3M - 43.5M, respectively. More news on: IRIDEX Corporation, Healthcare stocks news, Earnings news and commentary, , Read more ...
MOUNTAIN VIEW, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today provided preliminary operational and financial results for the fourth quarter and full year ended December 28, 2019. Highlights Total revenue for the fourth quarter of 2019 expected to ...
The following slide deck was published by IRIDEX Corporation in conjunction with this Read more ...
IRIDEX Corporation (IRIX) Q3 2019 Earnings Conference Call November 7, 2019 5:00 PM ET Company Participants Leigh Salvo – Head of Investors Relations Dave Bruce – Chief Executive Officer Romeo Dizon – Vice President of Finance Conference Call Participants ...
IRIDEX (NASDAQ: IRIX ): Q3 GAAP EPS of -$0.13 beats by $0.04 . More news on: IRIDEX Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...
MOUNTAIN VIEW, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the third quarter ended September 28, 2019. Third Quarter Highlights Total revenue of $10.7 million Cyclo G6® product family revenue of $3.0 million...
MOUNTAIN VIEW, Calif., Nov. 05, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the upcoming Stifel Healthcare Conference in New York City. David I. Bruce, IRIDEX’s President and Chief Executive Officer, is scheduled t...
MOUNTAIN VIEW, Calif., Oct. 28, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the appointment of Robert Gunst as Chairman of the Board, effective October 23, 2019. Concurrent with this appointment, Ruediger Naumann-Etienne departed from the Board of Directors as...
MOUNTAIN VIEW, Calif., Oct. 24, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the third quarter of 2019 after the close of trading on Thursday, November 7, 2019. The Company’s management team will host ...
News, Short Squeeze, Breakout and More Instantly...
MOUNTAIN VIEW, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial resul...
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...